MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 2014-11-19 for IMPAX CV OUTBOUND (RESULTS MANAGEMENT 2.08) IMPAX CV 2.08 manufactured by Agfa Healthcare Corporation.
[5031449]
Agfa submitted mdr report #1225058-2010-00001 to the fda on june 7, 2010 for a site in the us. A (b)(6) occurrence is being reported for the same issue/same device: impax cv resulted management administration tool (rmat). This is an internal discovery determined during the implementation of the associated problem correction plan, rmat verification, as reported in fda z-2112-10. (b)(6).
Patient Sequence No: 1, Text Type: D, B5
[12584876]
An agfa clinical analyst performed a retro-analysis and reported the findings to agfa service and agfa product quality manager. Agfa's investigation into this occurence of rmat customization has revealed that this specific change had the potential to introduce clinical inaccuracies in patient reports. Specifically: original measurement label was "post trab muscular two peak grad" - this was changed to "pda pk grad". Potential impact: if the change was made after reports had been generated with the original sentence selected, those reported prior to the change could display incorrect clinical data if viewed in rm or if used as a template for a repeat study on that patient - in this example the two disease states are very different, leading to potential incorrect diagnosis. On 11/2014: also, if the measurement (id/hlcode) is used to populate a findings sentence in the system, all reports made after the edit with the finding and measurement selected will also be affected. As stated above, if the change was made after reports had been generated with the original sentence of "post trab muscular two peak grad" - the measurement label would not read as the reading physician intended, but rather would be changed to "pda pk grad. " there has been no reported patient harm for this occurrence. A reportable correction is underway for this issue and has been reported to the fda via reference #z-2112-10. Agfa will follow the rmat post market verification work instructions to correct the sentence finding. Any further investigation for the site described in this report will be documented in the ongoing cfr part 806 reporting. (b)(4).
Patient Sequence No: 1, Text Type: N, H10
| Report Number | 1225058-2014-04236 |
| MDR Report Key | 4278927 |
| Report Source | 07 |
| Date Received | 2014-11-19 |
| Date of Report | 2014-11-14 |
| Date of Event | 2014-10-22 |
| Date Mfgr Received | 2014-10-22 |
| Device Manufacturer Date | 2002-03-01 |
| Date Added to Maude | 2014-12-01 |
| Event Key | 0 |
| Report Source Code | Manufacturer report |
| Manufacturer Link | Y |
| Number of Patients in Event | 0 |
| Adverse Event Flag | 3 |
| Product Problem Flag | 3 |
| Reprocessed and Reused Flag | 3 |
| Reporter Occupation | OTHER HEALTH CARE PROFESSIONAL |
| Health Professional | 3 |
| Initial Report to FDA | 3 |
| Report to FDA | 0 |
| Event Location | 0 |
| Manufacturer Contact | MRS. DEBORAH HUFF |
| Manufacturer Street | 10 SOUTH ACADEMY STREET |
| Manufacturer City | GREENVILLE SC 29601 |
| Manufacturer Country | US |
| Manufacturer Postal | 29601 |
| Manufacturer Phone | 8644211754 |
| Single Use | 0 |
| Remedial Action | OT |
| Previous Use Code | 3 |
| Event Type | 3 |
| Type of Report | 3 |
| Brand Name | IMPAX CV OUTBOUND (RESULTS MANAGEMENT 2.08) |
| Generic Name | PICTURE ARCHIVING AND COMMUNICATION |
| Product Code | LLX |
| Date Received | 2014-11-19 |
| Model Number | IMPAX CV 2.08 |
| Catalog Number | NA |
| Lot Number | NA |
| ID Number | NA |
| Device Availability | Y |
| Device Eval'ed by Mfgr | Y |
| Device Sequence No | 1 |
| Device Event Key | 0 |
| Manufacturer | AGFA HEALTHCARE CORPORATION |
| Manufacturer Address | 1 CROSSWIND RD. WESTERLY RI 02891 US 02891 |
| Patient Number | Treatment | Outcome | Date |
|---|---|---|---|
| 1 | 0 | 2014-11-19 |